Posted inGenetics
Organ Aging Linked to Breakdown in Immune Cell Interaction and Senescent Neutrophil Clearance
Credit: Kateryna Kon/Science Photo Library/Getty Images We may age at different rates, but none of us escapes aging. A study in…
Posted inBiotechnology
Toddler Diet Quality Linked to Childhood Growth Outcomes
Early childhood is a critical window for building the foundation of long-term health, yet how day-to-day eating patterns shape later…
Posted inBiotechnology
Noninvasive Acoustic Assessment of Feeding Skills in Preterm Infants With BPD
Oral feeding problems are a frequent, often hidden challenge in infants born preterm who develop bronchopulmonary dysplasia (BPD). These difficulties…
Posted inBiotechnology
Journal Cyborg and Bionic Systems Impact Factor Hits 20.9, Ranks Top in Robotics
Journal Citation Reports 2025 reveals that the Open Access journal Cyborg and Bionic Systems has achieved an Impact Factor of…
Posted inBiotechnology
Journal Cyborg and Bionic Systems Impact Factor Hits 20.9, Ranks Top Four
Journal of Cyborg and Bionic Systems has achieved a major milestone in the 2025 Journal Citation Reports, earning an Impact…
Posted inBiotechnology
Factors Behind Life Satisfaction in China’s Older Adults, Study of 1,578
A new analysis published in BMC Geriatrics is drawing attention to what really drives well-being in later life. Researchers, writing…
Posted inBiotechnology
Delayed vs Early Cord Clamping in Preterm Twins: Echocardiography Study
Preterm twins are often monitored in the minutes and hours after birth for subtle signs of cardiovascular instability. A new…
Posted inBiotechnology
‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics
After Eli Lilly dived into the psychedelics space with a $2.8 billion upfront acquisition of AtaiBeckley last week, industry experts…
Posted inBiotechnology
Omics and AI in Pediatric Environmental Health: Tools, Challenges, Cohort Insights
Early childhood is a decisive window for shaping lifelong health, yet young children are routinely exposed to a cocktail of…
Posted inBiotechnology
Randomized Phase II Trial Tests Nivolumab Then Nivolumab-Ipilimumab or Docetaxel
A new randomized Phase II clinical trial, OPTIM, is testing whether escalating immune therapy can improve outcomes for people with…